Variation among physician and patient preferences requires an individualized approach to communicating findings, Weill Cornell Medicine experts wrote in JACR.
The agency now recommends Aduhelm only for patients in the early stages of the disease, more closely aligning with the population tested during clinical trials.
David Zald, a professor of psychiatry at Rutgers Robert Wood Johnson Medical School. Photo: Jacqueline Robinson/ Rutgers University.
The Rutgers Center for Advanced Human Brain Imaging Research houses a state-of-the-art 3T MRI scanner that will help investigate Alzheimer's disease, addiction, and other conditions.
Massachusetts General Hospital doctors analyzed Coronary Artery Disease Reporting and Data System usage in their high-volume cardiac CT services center for the study.
Leading experts say there is no clinical evidence the controversial drug can help patients with cerebral amyloid angiopathy, a condition similar to Alzheimer's disease.
